Skip to content
★ Sign in to follow
DE

David Ellam

CFO
Silence Therapeutics plc
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 18 Jul 2016 for Silence Therapeutics plc, €265k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

David Ellam: trading record in brief

David Ellam has a single filing on record, published on 18 July 2016: a share grant of €265k in Silence Therapeutics plc. One trade is not enough to describe a pattern. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to David Ellam

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ◆
    Chief Financial OfficerExecutivesSilence Therapeutics plc
    221,240 GBP27FCA-NSM
    200,000 shares@ £1.1062100.0% of flowLondon Stock Exchange, AIMFCA-NSM:LSE20160718070009_012895268_20200330143558367_12760

1 of 1 declaration